Follow
Kina Höglund
Kina Höglund
Verified email at neuro.gu.se
Title
Cited by
Cited by
Year
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
TK Karikari, TA Pascoal, NJ Ashton, S Janelidze, AL Benedet, ...
The Lancet Neurology 19 (5), 422-433, 2020
7982020
Association of cerebrospinal fluid neurofilament light protein levels with cognition in patients with dementia, motor neuron disease, and movement disorders
B Olsson, E Portelius, NC Cullen, Å Sandelius, H Zetterberg, ...
JAMA neurology 76 (3), 318-325, 2019
1912019
Measurement of α-and β-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients
A Olsson, K Höglund, M Sjögren, N Andreasen, L Minthon, L Lannfelt, ...
Experimental neurology 183 (1), 74-80, 2003
1782003
Marked increase of β-amyloid(1–42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury
A Olsson, L Csajbok, M Öst, K Höglund, K Nylén, L Rosengren, ...
Journal of neurology 251, 870-876, 2004
1772004
Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia
E Bereczki, PT Francis, D Howlett, JB Pereira, K Höglund, A Bogstedt, ...
Alzheimer's & Dementia 12 (11), 1149-1158, 2016
1622016
Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology
E Portelius, B Olsson, K Höglund, NC Cullen, H Kvartsberg, ...
Acta neuropathologica 136, 363-376, 2018
1542018
An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders
NJ Ashton, A Hye, AP Rajkumar, A Leuzy, S Snowden, M Suárez-Calvet, ...
Nature Reviews Neurology 16 (5), 265-284, 2020
1512020
Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration
NJ Ashton, A Leuzy, YM Lim, C Troakes, T Hortobágyi, K Höglund, ...
Acta neuropathologica communications 7, 1-11, 2019
1512019
Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease
C Cicognola, G Brinkmalm, J Wahlgren, E Portelius, J Gobom, NC Cullen, ...
Acta neuropathologica 137, 279-296, 2019
1442019
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation
L Gaetani, K Höglund, L Parnetti, F Pujol-Calderon, B Becker, P Eusebi, ...
Alzheimer's research & therapy 10, 1-13, 2018
1342018
Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementia
B Olsson, J Hertze, R Lautner, H Zetterberg, K Nägga, K Höglund, ...
Journal of Alzheimer's Disease 33 (1), 45-53, 2013
1332013
Plasma levels of β-amyloid (1-40), β-amyloid (1-42), and total β-amyloid remain unaffected in adult patients with hypercholesterolemia after treatment with statins
K Höglund, O Wiklund, H Vanderstichele, O Eikenberg, E Vanmechelen, ...
Archives of neurology 61 (3), 333-337, 2004
1322004
The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer’s disease
K Höglund, KM Thelen, S Syversen, M Sjögren, K Von Bergmann, ...
Dementia and geriatric cognitive disorders 19 (5-6), 256-265, 2005
1182005
Neurochemical aftermath of repetitive mild traumatic brain injury
P Shahim, Y Tegner, B Gustafsson, M Gren, J Ärlig, M Olsson, N Lehto, ...
JAMA neurology 73 (11), 1308-1315, 2016
1142016
Prevalence of preclinical Alzheimer disease: comparison of current classification systems
S Kern, H Zetterberg, J Kern, A Zettergren, M Waern, K Höglund, ...
Neurology 90 (19), e1682-e1691, 2018
1092018
Characterization of tau in cerebrospinal fluid using mass spectrometry
E Portelius, SF Hansson, AJ Tran, H Zetterberg, P Grognet, ...
The Journal of Proteome Research 7 (5), 2114-2120, 2008
902008
Effect of HMG-CoA reductase inhibitors on β-amyloid peptide levels: implications for Alzheimer’s disease
K Höglund, K Blennow
CNS drugs 21, 449-462, 2007
892007
The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer’s disease
H Kvartsberg, T Lashley, CE Murray, G Brinkmalm, NC Cullen, K Höglund, ...
Acta Neuropathologica 137, 89-102, 2019
812019
Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathology
K Blennow, C Chen, C Cicognola, KR Wildsmith, PT Manser, ...
Brain 143 (2), 650-660, 2020
782020
Update on biomarkers for amyloid pathology in Alzheimer's disease
NJ Ashton, M Schöll, K Heurling, E Gkanatsiou, E Portelius, K Höglund, ...
Biomarkers in medicine 12 (7), 799-812, 2018
732018
The system can't perform the operation now. Try again later.
Articles 1–20